Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Hum Immunol. 2010 Sep 21;71(12):1191–1196. doi: 10.1016/j.humimm.2010.09.012

Table 1.

Patient Demographics

Variable n (%) Early HTx (n=43) Late HTx (n=52)
Total patients n = 95 AMR (n=8) No AMR (n=35) p value CAV (n=12) No CAV (n=40) p value
Age at HTx (yrs) 43.6 ± 15.6 48.3 ± 17.5 0.25 52.2 ± 12.8 51.2 ± 9.3 0.32
Male Gender(M:F) 6:2 26:9 0.18 10:2 32: 8 0.29
Ethnicity
Caucasian 6 (75%) 27 (77%) 0.12 9 (75%) 30 (75%) 0.57
African American 2 (25%) 6 (17%) 0.17 2 (16%) 8 (20%) 0.35
Other 0 (0%) 2 (5.7%) 1.0 1 (8.3%) 2 (5%) 0.43
LVAD prior to HTx 2 (25%) 8 (23%) 0.71 3 (25%) 11 (28%) 0.12
Mean f/u time (yrs) 1.8 ± 0.8 1.6 ± 0.7 0.55 8.9 ± 4.9 10.1 ± 6.4 0.31